tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CG Oncology Appoints Jim DeTore as Interim CFO
PremiumCompany AnnouncementsCG Oncology Appoints Jim DeTore as Interim CFO
11d ago
CG Oncology’s Promising Developments and Competitive Edge Drive Buy Rating
Premium
Ratings
CG Oncology’s Promising Developments and Competitive Edge Drive Buy Rating
11d ago
CG Oncology’s Promising Advances in NMIBC Treatment Drive Buy Rating with $75 Target
Premium
Ratings
CG Oncology’s Promising Advances in NMIBC Treatment Drive Buy Rating with $75 Target
11d ago
enGene price target raised to $10 from $4 at UBS
PremiumThe FlyenGene price target raised to $10 from $4 at UBS
13d ago
Optimistic Growth Potential for CG Oncology, Inc. Driven by Positive Regulatory Precedents and Strategic Pricing
Premium
Ratings
Optimistic Growth Potential for CG Oncology, Inc. Driven by Positive Regulatory Precedents and Strategic Pricing
19d ago
CG Oncology’s Phase 2 Study: A New Hope for High-Risk NMIBC
Premium
Company Announcements
CG Oncology’s Phase 2 Study: A New Hope for High-Risk NMIBC
29d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100